Translating today’s discoveries in childhood cancer research into tomorrow’s treatments.
Our strengths include cancer genomics, DNA damage, RNA biology and drug development. We are developing expertise in drug delivery, with a focus on nanotechnology-driven delivery of small RNA mimics and inhibitors.
